YTHDF2 and colorectal carcinoma: For instance, METTL14, which is underexpressed in colorectal cancer (CRC) and linked to a poor prognosis, reduces m6A levels on XIST and enhances YTHDF2-mediated XIST expression, thereby inhibiting tumor cell growth (Yang et al., 2020).